ArticleEuropean journal of cancer (Oxford, England : 1990)2016

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

Kilian Wistuba-Hamprecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.